News & Events about Spero Therapeutics Inc.
Globe Newswire
2 months ago
CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR...
Globe Newswire
2 months ago
Pursuant to the agreement, Spero will be receiving a $66 million upfront payment, received a $9 million direct equity investment in shares of Spero common stock, and is eligible for potential future milestone payments and tiered royaltiesCAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Spero ...
Globe Newswire
2 months ago
CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) ...
Thinking about buying stock in Twitter, TOP Ships, BioNano Genomics, LG Display, or Spero Therapeutics? Thinking about buying stock in Twitter, TOP Ships, BioNano Genomics, LG Display, or Spero Therapeutics? PR Newswire NEW YORK, Oct. 5, 2022 NEW YORK, Oct. 5, 2022 /PRNewswire...
Thinking about buying stock in AMC Entertainment, PG&E Corp, Xpeng, Tellurian, or Spero Therapeutics? Thinking about buying stock in AMC Entertainment, PG&E Corp, Xpeng, Tellurian, or Spero Therapeutics? PR Newswire NEW YORK, Sept. 26, 2022 NEW YORK, Sept. 26, 2022 /PRNewswire...